Ke Zhang
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Ke Zhang has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
- Jian Cao
Department of Radiology of The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
1 shared publication - Jie Qin
Department of Radiology, The Third Affiliated Hospital of Sun Yat-sen University, Guangzhou, P.R. China
1 shared publication - Na Cheng
Department of Pathology, The Third Affiliated Hospital, Sun Yat-sen University, No. 600 Tianhe Road, Guangzhou 510630, China
1 shared publication - Qing Xiang
Department of Radiology, The Third Affiliated Hospital of Sun Yat-sen University, Tianhe District, Tianhe Road 600, Guangzhou, 510620, China.
1 shared publication - Sidong Xie
Department of Radiology, The Third Affiliated Hospital of Sun Yat-sen University, Tianhe District, Tianhe Road 600, Guangzhou 510630, China
1 shared publication - Sisi Deng
Department of Radiology of The Third Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China
1 shared publication
Latest Publications
- 13 February 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (9) , 4050-4062
Application of the three-phase T1-derived model in staging liver fibrosis in chronic hepatitis: a comparative study with magnetic resonance elastography
Objective This study aims to evaluate the accuracy of a three-phase T1-derived model in staging liver fibrosis in patients with chronic hepatitis, in comparison with magnetic resonance elastography (MRE). Methods A total of 174 patients with chronic hepatitis were enrolled. The acquisition of three-phase longitudinal relaxation times (T1-Unenh = A, T1-DLP = B, T1HBP = C) from magnetic resonance enhancement examinations, as well as magnetic resonance elastography (MRE) and liver biopsy information for patients.Binary logistic regression was employed to construct models ABC. The diagnostic performance of these models was evaluated using the receiver operating characteristic (ROC) curve and DeLong’s test. Furthermore, the MRE and ABC models were subjected to a comprehensive analysis through 10-fold cross-validation. Results In all liver fibrosis stages (≥ F1-≥F4), both MRE and the ABC model showed moderate correlation with METAVIR fibrosis staging, with significant differences between groups (all P < 0.05). The area under the curve (AUC) for each group of the ABC model was above 0.84. DeLong’s test indicated that in the ≥ F2, ≥F3, and ≥ F4 groups, the ABC model was comparable to MRE (all P > 0.05). Ten-fold cross-validation further confirmed that only in the ≥ F3 group did the ABC model outperform MRE in terms of comprehensive performance. Conclusion This study successfully validated the effectiveness of the three-phase T1-derived model in staging liver fibrosis in patients with chronic hepatitis. In stages ≥ F2, ≥F3, and ≥ F4, it is comparable to MRE, especially showing superior application value in the ≥ F3 stage.
- 13 February 2025
- Published by Springer Nature in Abdominal Radiology
- Vol. 50 (9) , 4050-4062
Application of the three-phase T1-derived model in staging liver fibrosis in chronic hepatitis: a comparative study with magnetic resonance elastography
Objective This study aims to evaluate the accuracy of a three-phase T1-derived model in staging liver fibrosis in patients with chronic hepatitis, in comparison with magnetic resonance elastography (MRE). Methods A total of 174 patients with chronic hepatitis were enrolled. The acquisition of three-phase longitudinal relaxation times (T1-Unenh = A, T1-DLP = B, T1HBP = C) from magnetic resonance enhancement examinations, as well as magnetic resonance elastography (MRE) and liver biopsy information for patients.Binary logistic regression was employed to construct models ABC. The diagnostic performance of these models was evaluated using the receiver operating characteristic (ROC) curve and DeLong’s test. Furthermore, the MRE and ABC models were subjected to a comprehensive analysis through 10-fold cross-validation. Results In all liver fibrosis stages (≥ F1-≥F4), both MRE and the ABC model showed moderate correlation with METAVIR fibrosis staging, with significant differences between groups (all P < 0.05). The area under the curve (AUC) for each group of the ABC model was above 0.84. DeLong’s test indicated that in the ≥ F2, ≥F3, and ≥ F4 groups, the ABC model was comparable to MRE (all P > 0.05). Ten-fold cross-validation further confirmed that only in the ≥ F3 group did the ABC model outperform MRE in terms of comprehensive performance. Conclusion This study successfully validated the effectiveness of the three-phase T1-derived model in staging liver fibrosis in patients with chronic hepatitis. In stages ≥ F2, ≥F3, and ≥ F4, it is comparable to MRE, especially showing superior application value in the ≥ F3 stage.